Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04232267 · ClinicalTrials.gov registry record

Analysis of Sleep Study Data to Assess Depressive Burden

A clinical trial of Mood Disorders and Sleep Disorder, sponsored by Medibio Limited.

Completed
Registry status
329
Enrollment target
5
Study locations

NCT04232267 is a study of Mood Disorders and Sleep Disorder that has completed, run by Medibio Limited. The registered enrollment target is 329 participants, below the 929-participant average among 39 other Mood Disorders trials with a reported enrollment target (65% lower). The trial reports 5 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04232267, a study of Mood Disorders and Sleep Disorder, has completed, sponsored by Medibio Limited.

COMPLETED
Registry status
329 participants
Enrollment target
5
Study locations

Study Summary

This study evaluates the effectiveness of the MEB-001 device in assessing physiological parameters that provide a clinically significant depressive burden screener. This study uses objective physiological markers from MEB-001 to estimate the clinically significant depressive burden as subjectively reported by the subject with the Beck Depression Inventory - II (BDI-II).

Conditions Studied

Mood Disorders Sleep Disorder Depressive; Behavioral Disorder

Interventions

  • DEVICE MEB-001

Study Locations (5)

Ohio

  • Ohio Sleep Solutions - Columbus
  • Ohio Sleep Solutions - Grove City
  • Ohio Sleep Solutions - Hilliard

Minnesota

  • Restore Sleep Clinic - Blaine
  • Lakeland Sleep and CPAP - Plymouth

Trial Details

FieldValue
Enrollment Target 329 participants
Start Date 2020-01-13
Est. Completion 2022-03-01

Sponsor

Medibio Limited

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04232267

The ClinicalTrials.gov registry entry for NCT04232267 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 929-participant average among 39 other Mood Disorders trials with a reported enrollment target (65% lower). The listed sponsor is Medibio Limited, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Mood Disorders appearing as the primary indexed condition, and to 1 intervention - of which MEB-001 is the first listed.

NCT04232267 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Minnesota.

Frequently Asked Questions

What is clinical trial NCT04232267 about?

NCT04232267 is a clinical study titled "Analysis of Sleep Study Data to Assess Depressive Burden". This study evaluates the effectiveness of the MEB-001 device in assessing physiological parameters that provide a clinically significant depressive burden screener. This study uses objective physiological markers from MEB-001 to estimate the clinically significant depressive burden as subjectively r...

What is the current status of trial NCT04232267?

This trial is currently completed. The enrollment target is 329 participants. The study started on 2020-01-13. Estimated completion is 2022-03-01.

What conditions does trial NCT04232267 study?

This clinical trial studies the following conditions: Mood Disorders, Sleep Disorder, Depressive; Behavioral Disorder.

What interventions are being tested in trial NCT04232267?

The interventions under investigation include: MEB-001 (DEVICE).

Who is sponsoring clinical trial NCT04232267?

This trial is sponsored by Medibio Limited, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04232267 being conducted?

This trial has 5 study locations across Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mood Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mood Disorders

All registered trials for this condition

Sleep Disorder

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.